Enabling MedTech Translation in Academia: Redefining Value Proposition with Updated Regulations.
MedTech
innovation
medical device regulation
tissue engineering
translation
Journal
Advanced healthcare materials
ISSN: 2192-2659
Titre abrégé: Adv Healthc Mater
Pays: Germany
ID NLM: 101581613
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
15
07
2020
revised:
21
08
2020
pubmed:
17
9
2020
medline:
15
5
2021
entrez:
16
9
2020
Statut:
ppublish
Résumé
Academic institutions are becoming more focused on translating new technologies for clinical applications. A transition from "bench to bedside" is often described to take basic research concepts and methods to develop a therapeutic or diagnostic solution with proven evidence of efficacy at the clinical level while also fulfilling regulatory requirements. The regulatory environment is evolving in Europe with transition and grace periods for the full enforcement of the Medical Device Regulation 2017/745 (MDR), replacing the Medical Device Directive 93/42/EEC (MDD). These new guidelines increase demands for scientific, technical, and clinical data with reduced capacity in regulatory bodies creating uncertainty in future product certification. Academic translational activities will be uniquely affected by this new legislation. The barriers and threats to successful translation in academia can be overcome by strong clinical partnerships, close-industrial collaborations, and entrepreneurial programs, enabling continued product development to overcome regulatory hurdles, reassuring their foothold of medical device development.
Identifiants
pubmed: 32935923
doi: 10.1002/adhm.202001237
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2001237Informations de copyright
© 2020 Wiley-VCH GmbH.
Références
Z. S. Morris, S. Wooding, J. Grant, J. R. Soc. Med. 2011, 104, 510.
M. Abou-El-Enein, G. N. Duda, E. A. Gruskin, D. W. Grainger, Trends Biotechnol. 2017, 35, 100.
G. N. Duda, D. W. Grainger, M. L. Frisk, L. Bruckner-Tuderman, A. Carr, U. Dirnagl, K. M. Einhaupl, S. Gottschalk, E. Gruskin, C. Huber, C. H. June, D. J. Mooney, E. T. Rietschel, G. Schutte, W. Seeger, M. M. Stevens, R. Urban, A. Veldman, G. Wess, H.-D. Volk, Changing the Mindset in Life Sciences Toward Translation: A Consensus Science Translational Medicine 2014, 6, (264), 264cm12.
H. J. Marcus, C. J. Payne, A. Hughes-Hallett, A. P. Marcus, G. Z. Yang, A. Darzi, D. Nandi, BMJ 2016, 353, i2587.
J. F. Farragher, M. J. Elliott, S. A. Silver, Z. Lichner, A. Tsampalieros, Can. J. Kidney Heal. Dis. 2015, 2, 77.
J. M. Merigó, C. A. Cancino, F. Coronado, D. Urbano, Scientometrics 2016, 108, 559.
A. L. van der Laan, M. Boenink, Heal. Care Anal. 2015, 23, 32.
R. J. Kleiman, M. D. Ehlers, Mol. Biol. Cell 2019, 30, 2741.
J. West, A. Salter, W. Vanhaverbeke, H. Chesbrough, Res. Policy 2014, 43, 805.
M. Perkmann, V. Tartari, M. McKelvey, E. Autio, A. Broström, P. D’Este, R. Fini, A. Geuna, R. Grimaldi, A. Hughes, S. Krabel, M. Kitson, P. Llerena, F. Lissoni, A. Salter, M. Sobrero, Academic engagement and commercialisation: A review of the literature on university-industry relations Research Policy 2013, 42, (2), 423.
E. Lansac, I. Di Centa, F. Raoux, N. Bulman-Fleming, A. Ranga, A. Abed, M. Ba, A. Paolitto, D. Letourneur, A. Meddahi-Pellé, J. Thorac. Cardiovasc. Surg. 2009, 138, 718.
A. De Pieri, S. Ribeiro, D. Tsiapalis, D. Eglin, M. Bohner, P. Dubruel, P. Procter, D. I. Zeugolis, Y. Bayon, J. Mater. Sci. Mater. Med. 2018, 29, 129.
C. Ohmann, S. Canham, J. Demotes, G. Chêne, J. Lauritsen, H. Martins, R. V. Mendes, E. B. Nicolis, A. Svobodnik, F. Torres, Contemp. Clin. Trials Commun. 2017, 5, 153.
European Commission, European database on medical devices (EUDAMED) | Internal Market, Industry, Entrepreneurship and SMEs, https://ec.europa.eu/growth/sectors/medical-devices/new-regulations/eudamed_en, 2020.
European Commision, “MEDDEV 2.7/1 revision 4, Clinical evaluation: a guide for manufacturers and notified bodies, https://ec.europa.eu/docsroom/documents/17522/attachments/1/translations/en/renditions/native, 2016.
G. A. Van Norman, JACC Basic to Transl. Sci. 2016, 1, 277.
R. Collins, L. Bowman, M. Landray, R. Peto, N. Engl. J. Med. 2020, 382, 674.
HQIP, Proposal for a Medical Devices Registry - HQIP, https://www.hqip.org.uk/resource/proposal-for-a-medical-devices-registry/#.Xr-cTdNKjcs, 2020.
Food and Drug Administration, Real-World Evidence | FDA, https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence, 2020.
F. Köckerling, T. Simon, M. Hukauf, A. Hellinger, R. Fortelny, W. Reinpold, R. Bittner, Ann. Surg. 2018, 268, 1097.
M. Cuggia, S. Combes, Yearb. Med. Inform. 2019, 28, 195.
L. F. Brass, M. H. Akabas, JCI Insight 2019, 4, e133009.
L. F. Brass, M. H. Akabas, L. D. Burnley, D. M. Engman, C. A. Wiley, O. S. Andersen, Acad. Med. 2010, 85, 692.
M. Boenink, L. van der Scheer, E. Garcia, S. van der Burg, Nanoethics 2018, 12, 181.
V. Drozdoff, D. Fairbairn, Cold Spring Harb. Perspect. Med. 2015, 5, 021014.
B. Bhhatarai, W. P. Walters, C. E. C. A. Hop, G. Lanza, S. Ekins, Nat. Mater. 2019, 18, 418.
H. Ahn, Second Generation Patents in Pharmaceutical Innovation, Nomos Verlagsgesellschaft, Baden-Baden, Germany 2014.
M. R. Barnes, L. Harland, S. M. Foord, M. D. Hall, I. Dix, S. Thomas, B. I. Williams-Jones, C. R. Brouwer, Nat. Rev. Drug Discovery 2009, 8, 701.
B. J. van Meer, H. de Vries, K. S. A. Firth, J. van Weerd, L. G. J. Tertoolen, H. B. J. Karperien, P. Jonkheijm, C. Denning, A. P. IJzerman, C. L. Mummery, Biochem. Biophys. Res. Commun. 2017, 1, 6.
C. S. Pridgeon, C. Schlott, M. W. Wong, M. B. Heringa, T. Heckel, J. Leedale, L. Launay, V. Gryshkova, S. Przyborski, R. N. Bearon, E. L. Wilkinson, T. Ansari, J. Greenman, D. F. G. Hendriks, S. Gibbs, J. Sidaway, R. L. Sison-Young, P. Walker, M. J. Cross, B. K. Park, C. E. P. Goldring, Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms Archives of Toxicology 2018, 92, (2), 557.
J. H. Linehan, A. Chaney, Sci. Transl. Med. 2010, 2, 63mr6.
L. L. Restifo, G. R. Phelan, Dis. Model. Mech. 2011, 4, 423.
C. Chauvierre, R. Aid-Launais, J. Aerts, F. Chaubet, M. Maire, L. Chollet, L. Rolland, R. Bonafé, S. Rossi, S. Bussi, C. Cabella, L. Dézsi, T. Fülöp, J. Szebeni, Y. Chahid, K. H. Zheng, E. S. G. Stroes, D. Le Guludec, F. Rouzet, D. Letourneur, Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases Marine Drugs 2019, 17, (12), 699.
D. W. Grainger, H. C. van der Mei, P. C. Jutte, J. J. A. M. van den Dungen, M. J. Schultz, B. F. A. M. van der Laan, S. A. J. Zaat, H. J. Busscher, Biomaterials 2013, 34, 9237.
P. D. Loftus, C. T. Elder, T. D'Ambrosio, J. T. Langell, Clin. Transl. Med. 2015, 4, 15.
S. Gehr, C. C. Garner, Cell 2016, 165, 765.
S. Ribeiro, M. Ricci, A. Von Der Lieth, Y. Bayon, D. I. Zeugolis, S. Pelayo, I. Marque, L. Pazart, Proceedings of the 12th International Joint Conference on Biomedical Engineering Systems and Technologies, 2019, 5, 603.
S. A. Maher, R. Kyle, B. F. Morrey, M. J. Yaszemski, J. Am. Acad. Orthop. Surg. 2019, 27, e9.
J. Kimmelman, J. S. Mogil, U. Dirnagl, PLoS Biol. 2014, 12, e1001863.
R. E. Meyer, P. F. Griner, J. Weissman, Proc. Assoc. Am. Physicians 1998, 110, 513.
Science Foundation Ireland, SFI discover | Engagement | Science Foundation Ireland, https://www.sfi.ie/engagement/sfi-discover/, 2020.
T. A. Battaglia, K. M. Freund, J. S. Haas, N. Casanova, S. Bak, H. Cabral, R. A. Freedman, K. B. White, S. C. Lemon, Contemp. Clin. Trials 2020, 93, 106007.
M. Abou-El-Enein, G. Bauer, P. Reinke, M. Renner, C. K. Schneider, Trends Mol. Med. 2014, 20, 632.
M. Blüher, S. J. Saunders, V. Mittard, R. Torrejon Torres, J. A. Davis, R. Saunders, Front. Med. 2019, 6, 278.
H. D. Volk, M. M. Stevens, D. J. Mooney, D. W. Grainger, G. N. Duda, Sci. Transl. Med. 2015, 7, 282cm2.